---
title: "Lila Dabill, PhD: Sarm1 Neural Knockout Links to Obesity Prevention — ENDO 2026 Rising Star Q&A"
id: "endocrine-news-1-star-power-2026-q-a-with-lila-dabill-phd"
canonical_url: "https://medichelpline.com/clinical-feed/endocrine-news-1-star-power-2026-q-a-with-lila-dabill-phd"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "Endocrine News"
source_url: "https://endocrinenews.endocrine.org/star-power-2026-qa-with-lila-dabill-phd/"
published_at: "2026-08-21T12:50:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Lila Dabill, PhD: Sarm1 Neural Knockout Links to Obesity Prevention — ENDO 2026 Rising Star Q&A
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/endocrine-news-1-star-power-2026-q-a-with-lila-dabill-phd
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** Endocrine News
- **Source URL:** [Original Journal Publication](https://endocrinenews.endocrine.org/star-power-2026-qa-with-lila-dabill-phd/)
- **Published At:** 2026-08-21T12:50:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The article profiles **Lila Dabill**, PhD student at Washington University in St. Louis, winner of the Basic Science category in the ENDO 2026 Rising Star Power Talks. - Rising Star Power Talks at **ENDO** features 15 early-career researchers who present brief, high-impact talks; winners were selected by judges and audience. - Dabill presented work from the Scheller lab on the NADase enzyme **Sarm1**, known as the central executioner of Wallerian axon degeneration in the nervous system. - In mouse models, whole-nerve knockout of **Sarm1** prevented high fat diet–induced obesity, insulin resistance, and liver steatosis. - Metabolic cage and thermogenesis testing showed the prevented weight gain was independent of energy expenditure, activity, and thermogenesis. - The lab is investigating the gut as a potential mechanism, testing whether Sarm1 neural knockout protects against high fat diet–induced gut dysfunction and enteric neuropathy using functional assays and whole-mount imaging. - If confirmed, **Sarm1** inhibitors might be explored as therapeutic agents that could target neuropathy, insulin resistance, fatty liver, and weight gain together. - Dabill described the elevator-pitch presentation format as valuable for communicating the core importance of research to diverse audiences. - She credits the **Endocrine Society** with providing a collaborative environment that supported her research development and professional growth, and she plans to continue participating in ENDO meetings. - Dabill plans to defend her PhD in spring 2027, seek a postdoctoral position, and ultimately establish an independent lab focused on metabolism and neural regulation of metabolism.
## Clinical Analysis & Structured Key Points
[Skip to content](https://endocrinenews.endocrine.org/star-power-2026-qa-with-lila-dabill-phd/#wp--skip-link--target) [Endocrine News](https://endocrinenews.endocrine.org) [![Endocrine News](https://endocrinenews.endocrine.org/wp-content/uploads/es-reversed.svg)](https://endocrinenews.endocrine.org/) * [Topics](https://endocrinenews.endocrine.org/category/health-topic/diabetes/) * [Diabetes](https://endocrinenews.endocrine.org/category/health-topic/diabetes/) * [Obesity](https://endocrinenews.endocrine.org/category/health-topic/obesity/) * [Adrenal](https://endocrinenews.endocrine.org/category/health-topic/adrenal/) * [Bone and Mineral](https://endocrinenews.endocrine.org/category/health-topic/bone-and-mineral/) * [Cardiometabolic](https://endocrinenews.endocrine.org/category/health-topic/cardiometabolic/) * [Endocrine Disruptors](https://endocrinenews.endocrine.org/category/health-topic/endocrine-disruptors/) * [Head Glands](https://endocrinenews.endocrine.org/category/health-topic/head-glands/) * [Kidney Issues](https://endocrinenews.endocrine.org/category/health-topic/kidney-issues/) * [Neoplasia and Cancer](https://endocrinenews.endocrine.org/category/health-topic/neoplasia-and-cancer/) * [Pancreas](https://endocrinenews.endocrine.org/category/health-topic/pancreas/) * [Reproductive Issues](https://endocrinenews.endocrine.org/category/health-topic/reproductive-issues/) * [Thyroid](https://endocrinenews.endocrine.org/category/health-topic/thyroid/) * [Pediatric Health](https://endocrinenews.endocrine.org/category/patient-populations/pediatric-health/) * [Men’s Health](https://endocrinenews.endocrine.org/category/patient-populations/mens-health/) * [Women’s Health](https://endocrinenews.endocrine.org/category/patient-populations/womens-health/) * [Why Endocrinology?](https://endocrinenews.endocrine.org/category/why-endocrinology/) * [Practice](https://endocrinenews.endocrine.org/category/practice/) * [Your Practice](https://endocrinenews.endocrine.org/category/practice/your-practice/) * [Your Patients](https://endocrinenews.endocrine.org/category/practice/your-patients/) * [Product / Technology](https://endocrinenews.endocrine.org/category/practice/product-technology/) * [Endocrinology Workforce](https://endocrinenews.endocrine.org/category/endocrinology-workforce/) * [Lab Notes](https://endocrinenews.endocrine.org/category/lab-notes/) * [Q&A](https://endocrinenews.endocrine.org/category/lab-notes/q-a/) * [Your Laboratory](https://endocrinenews.endocrine.org/category/your-laboratory/) * [Products and Technological Advancements in Endocrinology](https://endocrinenews.endocrine.org/category/lab-notes/products-technology/) * [Advocacy](https://endocrinenews.endocrine.org/category/advocacy/) * [Clinical](https://endocrinenews.endocrine.org/category/advocacy/clinical/) * [Research](https://endocrinenews.endocrine.org/category/advocacy/research/) * [InTouch](https://endocrinenews.endocrine.org/intouch/) * [Member News](https://endocrinenews.endocrine.org/category/in-touch/member-news-in-touch/) * [Society News](https://endocrinenews.endocrine.org/category/in-touch/society-news/) * [Podcast](https://www.endocrine.org/podcast) * [Current Issue Download](https://endocrinenews.endocrine.org/magazine/current-issue/) * [My Profile](https://ams.endocrine.org/eweb/) * [Log In](https://endocrinenews.endocrine.org/auth/login) * [Log Out](https://endocrinenews.endocrine.org/auth/logout) * [Topics](https://endocrinenews.endocrine.org/category/health-topic/diabetes/) * [Diabetes](https://endocrinenews.endocrine.org/category/health-topic/diabetes/) * [Obesity](https://endocrinenews.endocrine.org/category/health-topic/obesity/) * [Adrenal](https://endocrinenews.endocrine.org/category/health-topic/adrenal/) * [Bone and Mineral](https://endocrinenews.endocrine.org/category/health-topic/bone-and-mineral/) * [Cardiometabolic](https://endocrinenews.endocrine.org/category/health-topic/cardiometabolic/) * [Endocrine Disruptors](https://endocrinenews.endocrine.org/category/health-topic/endocrine-disruptors/) * [Head Glands](https://endocrinenews.endocrine.org/category/health-topic/head-glands/) * [Kidney Issues](https://endocrinenews.endocrine.org/category/health-topic/kidney-issues/) * [Neoplasia and Cancer](https://endocrinenews.endocrine.org/category/health-topic/neoplasia-and-cancer/) * [Pancreas](https://endocrinenews.endocrine.org/category/health-topic/pancreas/) * [Reproductive Issues](https://endocrinenews.endocrine.org/category/health-topic/reproductive-issues/) * [Thyroid](https://endocrinenews.endocrine.org/category/health-topic/thyroid/) * [Pediatric Health](https://endocrinenews.endocrine.org/category/patient-populations/pediatric-health/) * [Men’s Health](https://endocrinenews.endocrine.org/category/patient-populations/mens-health/) * [Women’s Health](https://endocrinenews.endocrine.org/category/patient-populations/womens-health/) * [Why Endocrinology?](https://endocrinenews.endocrine.org/category/why-endocrinology/) * [Practice](https://endocrinenews.endocrine.org/category/practice/) * [Your Practice](https://endocrinenews.endocrine.org/category/practice/your-practice/) * [Your Patients](https://endocrinenews.endocrine.org/category/practice/your-patients/) * [Product / Technology](https://endocrinenews.endocrine.org/category/practice/product-technology/) * [Endocrinology Workforce](https://endocrinenews.endocrine.org/category/endocrinology-workforce/) * [Lab Notes](https://endocrinenews.endocrine.org/category/lab-notes/) * [Q&A](https://endocrinenews.endocrine.org/category/lab-notes/q-a/) * [Your Laboratory](https://endocrinenews.endocrine.org/category/your-laboratory/) * [Products and Technological Advancements in Endocrinology](https://endocrinenews.endocrine.org/category/lab-notes/products-technology/) * [Advocacy](https://endocrinenews.endocrine.org/category/advocacy/) * [Clinical](https://endocrinenews.endocrine.org/category/advocacy/clinical/) * [Research](https://endocrinenews.endocrine.org/category/advocacy/research/) * [InTouch](https://endocrinenews.endocrine.org/intouch/) * [Member News](https://endocrinenews.endocrine.org/category/in-touch/member-news-in-touch/) * [Society News](https://endocrinenews.endocrine.org/category/in-touch/society-news/) * [Podcast](https://www.endocrine.org/podcast) * [Current Issue Download](https://endocrinenews.endocrine.org/magazine/current-issue/) * [My Profile](https://ams.endocrine.org/eweb/) * [Log In](https://endocrinenews.endocrine.org/auth/login) * [Log Out](https://endocrinenews.endocrine.org/auth/logout) Search Search [Current Issue Download](https://endocrinenews.endocrine.org/magazine-issues/august-2026/) [Login](https://endocrinenews.endocrine.org/auth/login/?redirect=https://endocrinenews.endocrine.org/star-power-2026-qa-with-lila-dabill-phd/) ![](https://endocrinenews.endocrine.org/wp-content/themes/mg-starter/assets/images/Endocrine_News_standard_logo.svg) * * * # Star Power 2026: Q&A with Lila Dabill, PhD By Mark A. Newman August 21, 2026 Print this article Share this article ![](https://endocrinenews.endocrine.org/wp-content/uploads/dabill-lab-scaled-e1786471283255.jpeg) ##### Early-career and in-training members get their chances to shine brightly at the Rising Star Power Talks that take place at ENDO each year. _Endocrine News_ caught up with this year’s Basic Science winner, Lila Dabill, a PhD student at Washington University in St. Louis, Mo., to learn more about her research, future plans, the impact the Endocrine Society has had on her career, and more. Each year, one of the most popular events at **ENDO** is the Rising Stars Power Talks and **ENDO 2026** was certainly no different. These talks see 15 early-career and in-training Endocrine Society members get the chance to communicate their groundbreaking research with an audience of their peers. The judges and audience decided the winners of this blitz style research communication competition, and this year’s winners were: Basic Science: **Lila Dabill,** PhD student, Washington University, St. Louis, Mo.; Clinical Science: **Brittany Weisbrot,** internal medicine resident, Loyola University Medical Center, Maywood, Ill.; Translational Science: **[Dillon Boulton, PhD](https://endocrinenews.endocrine.org/star-power-2026-qa-with-dillon-boulton-phd/)** , postdoc fellow, Department of Pathology, University of Colorado – Anshutz Medical Campus, Aurora, Colo.; and the Audience’s Choice was **Konstantinos Stefanakis MD, PhD** (candidate), cardiology fellow, postdoctoral research fellow, Harvard Medical School, Beth Israel Medical Center, Boston, Mass. _Endocrine News_ scored a front-row seat to the proceedings and caught up with this year’s winners to find out more about their award-winning research, their future research goals, how it felt to present in a room of their peers, and more. In this second of four installments, we chat with this year’s Basic Science winner, Lila Dabill, a PhD student at Washington University in St. Louis, Mo., to learn more about her research, future plans, the impact the Endocrine Society has had on her career, and more. ### **_Endocrine News_** : **Tell us a little bit about the research that you presented at the session.** **Lila Dabill** : I had the pleasure of presenting on my current PhD thesis work in Dr. Erica Scheller’s Lab. We are examining an NADase enzyme called Sarm1 found primarily within the nervous system. Sarm1 is the central executioner of Wallerian axon degeneration which occurs after injury, and because of this, multiple companies are already developing Sarm1 inhibitors as a treatment method for neuropathy and neurodegenerative diseases. We have discovered that knocking out Sarm1 in all the nerves of the mice prevents the onset of high fat diet induced obesity, insulin resistance, and liver steatosis. We performed rigorous metabolic caging assessments and thermogenic testing and found that the prevention in weight gain is independent of energy expenditure, activity, and thermogenesis. We are now moving our hypothesis to the gut as a possible mechanism for the prevention of weight gain. Our goal now is to perform functional assays and wholemount imaging techniques to determine whether Sarm1 neural knockout is protecting against high fat diet induced gut dysfunction and enteric neuropathy. Once this work is complete, we can explore the exciting potential of using Sarm1 inhibitors as a way to treat multiple facets of obesity and metabolic dysfunction simultaneously. ![](https://endocrinenews.endocrine.org/wp-content/uploads/Rising-star-winners-1024x683.jpg)**_From left to right are the 2026 Rising Star Power Talks winners: Translational Science: Dillon Boulton, PhD, postdoc fellow, Department of Pathology, University of Colorado – Anshutz Medical Campus, Aurora, Colo.; Basic Science: Lila Dabill, PhD student, Washington University, St. Louis, Mo.; Brittany Weisbrot, internal medicine resident, Loyola University Medical Center, Maywood, Ill.; and the Audience’s Choice was Konstantinos Stefanakis MD, PhD (candidate), cardiology fellow, postdoctoral research fellow, Harvard Medical School, Beth Israel Medical Center, Boston, Mass._** ### **_EN_** : **What inspired you to undertake this specific research?** **Dabill** : Obesity and type 2 diabetes are a rising issue within the U.S., and there aren’t enough treatment methods available for these patients. Current methods of treatment can cause concerning side effects and aren’t effective in every patient. This project has been an exciting opportunity for me to explore issues of obesity and type 2 diabetes from a new angle. It has been interesting and exciting to uncover how Sarm1 in the nervous system plays a role in metabolic dysfunction and weight gain, and it is my hope that this work will provide insight into new neural mechanisms for the treatment of obesity and type 2 diabetes. > ![](https://endocrinenews.endocrine.org/wp-content/uploads/dabill-headshot-769x1024.jpg) > “The collaborative and supportive environment of the Endocrine Society has supported growth and rigor in my research and challenged me to try new approaches. I’m grateful for the opportunity to learn from experts in the field and for the exciting discussions that follow. I can’t wait to learn more and meet new people at **ENDO 2027**.” – **Lila Dabill** , PhD student, Washington University, St. Louis, Mo. ### **_EN_** : **How did it feel to present your work in such a lively environment among your peers and mentors?** **Dabill** : It was thrilling to have the opportunity to present my work in such a fast-paced, elevator pitch style. I find this style of presentation very satisfying to put together since it forces the speaker to stay succinct and really get to the heart of why the research matters. It was great getting to witness that from all the other excellent Rising Star scholars during the session as well. As scientists, it’s crucial that we practice the ability to pitch our work to a wide audience and convince them that our work is important for the benefit of the general public. I’m thankful that the Endocrine Society gave me this opportunity to practice that this year. ### **_EN_ : Can you explain what sort of impact the Endocrine Society has had on your research career?** **Dabill** : The Endocrine Society has served as a great home-base society for me during my PhD thus far. I’ve had the pleasure of attending and presenting over the past few years and look forward to continuing my involvement. The collaborative and supportive environment of the Endocrine Society has supported growth and rigor in my research and challenged me to try new approaches. I’m grateful for the opportunity to learn from experts in the field and for the exciting discussions that follow. I can’t wait to learn more and meet new people at **ENDO 2027**. ![](https://endocrinenews.endocrine.org/wp-content/uploads/dabill-podium-w-crowd-1024x683.jpg)Dabill makes the case for her science in front of a packed room full of peers during the 2026 Rising Star Power Talks during ENDO 2026 in Chicago, Ill., in June. ### **_EN_** : **What’s next for you and your research? Where do you go from here?** **Dabill** : We’re in an exciting phase of my research project where we are now exploring the gut phenotypes and mechanisms of Sarm1 neural knockout with high fat diet. Results from this work will inform on whether Sarm1 neural knockout is protecting against obesity by preventing high fat diet induced gut dysmotility and dysregulated gut-brain-axis signaling. It is exciting to consider a treatment option, such as Sarm1 inhibitors, for obesity and type 2 diabetes where we could target issues of neuropathy, insulin resistance, fatty liver, and weight gain simultaneously. As for me, I am planning on defending in spring of 2027 and will begin looking for a post-doctoral position. My long-term goal is to establish a lab as a PI in the field of metabolism and neural regulation of metabolism. _Newman has been the editor of_ Endocrine News _since he began working for the Endocrine Society in 2013. Feel free to send him story ideas at:__mnewman@endocrine.org_ _._ * * * ## TOPICS IN THIS ARTICLE: [Q&A](https://endocrinenews.endocrine.org/category/lab-notes/q-a/) ←[EDC Exposure May Be Linked to High Blood Pressure During Pregnancy](https://endocrinenews.endocrine.org/edc-exposure-may-be-linked-to-high-blood-pressure-during-pregnancy/) ## RELATED ARTICLES * ![Star Power 2026: Q&A with Dillon Boulton, PhD](https://endocrinenews.endocrine.org/wp-content/uploads/boulton-lab-scaled-e1786469871957-1024x577.jpeg) ### [ Star Power 2026: Q&A with Dillon Boulton, PhD ](https://endocrinenews.endocrine.org/star-power-2026-qa-with-dillon-boulton-phd/) August 18, 2026 * ![Pacific Overtures: Q&A with 2025 C. Wayne Bardin International Travel Award Winner Yoshimoto Hoshino, MD, PhD](https://endocrinenews.endocrine.org/wp-content/uploads/Yoshitomo-Hoshino.jpg) ### [ Pacific Overtures: Q&A with 2025 C. Wayne Bardin International Travel Award Winner Yoshimoto Hoshino, MD, PhD ](https://endocrinenews.endocrine.org/pacific-overtures-qa-with-2025-c-wayne-bardin-international-travel-award-winner-yoshimoto-hoshino-md-phd/) August 12, 2025 * ![The Path of Kahn: Q&A with Barbara Kahn, MD, Recipient of the 2025 Roy O. Greep Award for Outstanding Research](https://endocrinenews.endocrine.org/wp-content/uploads/B-Kahn-1-819x1024.jpg) ### [ The Path of Kahn: Q&A with Barbara Kahn, MD, Recipient of the 2025 Roy O. Greep Award for Outstanding Research ](https://endocrinenews.endocrine.org/the-path-of-kahn-qa-with-barbara-kahn-md-recipient-of-the-2025-roy-o-greep-award-for-outstanding-research/) April 17, 2025 * * * ADVERTISEMENT ![August 2026](https://endocrinenews.endocrine.org/wp-content/uploads/08.26_coverPROOF001-749x1024.jpg) [View Archives](https://endocrinenews.endocrine.org/magazine-issues/) ADVERTISEMENT ADVERTISEMENT ![](https://endocrinenews.endocrine.org/wp-content/themes/mg-starter/assets/images/scientists_optim-1024x569.jpg) ## Join the Global Movement Advancing Endocrine Science and Medicine Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities. [Join Today](https://www.endocrine.org/membership) [![](https://endocrinenews.endocrine.org/wp-content/themes/mg-starter/assets/images/Endocrine_Society_Logo.webp)](https://www.endocrine.org/) ![](https://endocrinenews.endocrine.org/wp-content/themes/mg-starter/assets/images/Endocrine_News_standard_logo.svg) [![](https://endocrinenews.endocrine.org/wp-content/themes/mg-starter/assets/images/facebook.svg)](http://www.facebook.com/pages/The-Endocrine-Society/93758955863)[![](https://endocrinenews.endocrine.org/wp-content/themes/mg-starter/assets/images/x.svg)](https://x.com/TheEndoSociety)[![](https://endocrinenews.endocrine.org/wp-content/themes/mg-starter/assets/images/linkedin.svg)](https://www.linkedin.com/company/the-endocrine-society/) ## Research * * * ### Health Topics [Adrenal](https://endocrinenews.endocrine.org/category/health-topic/adrenal/) [Bone and Mineral](https://endocrinenews.endocrine.org/category/health-topic/adrenal/) [Cardiometabolic](https://endocrinenews.endocrine.org/category/health-topic/cardiometabolic/) [Diabetes](https://endocrinenews.endocrine.org/category/health-topic/diabetes/) [Endocrine Disruptors](https://endocrinenews.endocrine.org/category/health-topic/endocrine-disruptors/) [Head Glands](https://endocrinenews.endocrine.org/category/health-topic/head-glands/) [Kidney Issues](https://endocrinenews.endocrine.org/category/health-topic/kidney-issues/) [Neoplasia and Cancer](https://endocrinenews.endocrine.org/category/health-topic/neoplasia-and-cancer/) [Obesity](https://endocrinenews.endocrine.org/category/health-topic/obesity/) [Pancreas](https://endocrinenews.endocrine.org/category/health-topic/pancreas/) [Reproductive Issues](https://endocrinenews.endocrine.org/category/health-topic/reproductive-issues/) [Thyroid](https://endocrinenews.endocrine.org/category/health-topic/thyroid/) [Transgender Health](https://endocrinenews.endocrine.org/category/health-topic/transgender-health/) ### Patient Populations [](https://endocrinenews.endocrine.org/category/health-topic/adrenal/)[Health Disparities](https://endocrinenews.endocrine.org/category/health-topic/bone-and-mineral/) [Men’s Health](https://endocrinenews.endocrine.org/category/patient-populations/mens-health/) [Pediatric Health](https://endocrinenews.endocrine.org/category/patient-populations/pediat
## Related Clinical Research

- [GLP-1 receptor agonists and PMOS: evidence, mechanisms, and who may benefit](https://medichelpline.com/clinical-feed/medical-news-today-0-can-glp-1s-really-help-treat-pmos-experts-answer-3-key-questions.md)
- [Konstantinos Stefanakis: Blood-based Proteomics to Detect MASLD/MASH — ENDO 2026 Audience Choice](https://medichelpline.com/clinical-feed/endocrine-news-0-star-power-2026-q-a-with-konstantinos-stefanakis-md.md)
- [Exercise Modalities for Adults with Type 2 Diabetes and Obesity: Comparative Effects on Visceral F](https://medichelpline.com/clinical-feed/frontiers-in-immunology-19-exercise-modalities-for-adults-with-type-2-diabetes-mellitus-and-obesity.md)
- [Undiagnosed type 2 diabetes presenting as DKA with hypertriglyceridemia-induced acute pancreatitis](https://medichelpline.com/clinical-feed/cmaj-1-undiagnosed-type-2-diabetes-presenting-as-diabetic-ketoacidosis-with.md)
- [Post‑Bariatric Hypoglycemia After Weight‑Loss Surgery: Prevalence, Costs, and Clinical Impact](https://medichelpline.com/clinical-feed/endocrine-news-1-the-hidden-side-effect-of-weight-loss-surgery-severe-low-blood-sugar.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.